Hypokalemic periodic paralysis synonyms

Hypokalemic periodic paralysis, often abbreviated as HypoPP, is a rare genetic muscle disorder characterized by sudden episodes of muscle weakness associated with low serum potassium levels. It is also historically referred to as familial hypokalemic periodic paralysis, though the condition can be caused by both hereditary mutations and, in rare instances, acquired factors like thyrotoxicosis.

What are the common synonyms for Hypokalemic periodic paralysis?

In medical literature and clinical documentation, you may encounter several terms used to describe Hypokalemic periodic paralysis. Because this condition was historically classified based on its clinical presentation rather than its genetic cause, the naming conventions have evolved over time. Common synonyms include:

• Familial hypokalemic periodic paralysis


• Hypokalemic familial periodic paralysis


• Westphal’s disease (a historical eponym)


• Hypokalemic periodic paralysis type 1 (associated with CACNA1S mutations)


• Hypokalemic periodic paralysis type 2 (associated with SCN4A mutations)

While "HypoPP" is the most frequent abbreviation used by specialists, patients may also see it categorized under the broader umbrella of "periodic paralyses" or "channelopathies," as the disease is caused by dysfunction in the ion channels of muscle cells.

Why does this condition have so many different names?

The variety of names for Hypokalemic periodic paralysis stems from a transition in medical classification. Early physicians named the condition based on symptoms—specifically, the periodic nature of the weakness and the low potassium levels observed during attacks. As clinical genetics advanced, researchers identified that Hypokalemic periodic paralysis is not a single disease entity but a group of disorders caused by mutations in different genes. Consequently, the field shifted toward using genetic classification (Type 1 vs. Type 2) to better reflect the underlying pathology. Older literature may still refer to the condition simply as "periodic paralysis," which can be confusing, as this term also encompasses hyperkalemic and normokalemic variants.

What are the official medical classifications for this condition?

To ensure consistency across international medical records, Hypokalemic periodic paralysis is tracked using standardized coding systems. These official identifiers help clinicians and researchers communicate accurately:

1. Orphanet: Listed as ORPHA:684, specifically categorized under "Hypokalemic periodic paralysis."


2. OMIM (Online Mendelian Inheritance in Man): The condition is cataloged under entries #170400 (Type 1) and #613345 (Type 2).


3. ICD-10-CM: Classified under code G72.3, which covers "Periodic paralysis."


4. NIH GARD: The Genetic and Rare Diseases Information Center uses "Hypokalemic periodic paralysis" as the primary term for their comprehensive patient resources.

Which name is preferred by medical professionals?

Today, the medical community prefers the term Hypokalemic periodic paralysis. This name is considered the most clinically accurate because it describes the hallmark physiological finding (hypokalemia) and the clinical manifestation (periodic paralysis). While geneticists may specify "CACNA1S-related" or "SCN4A-related" periodic paralysis for precision, the overarching term remains the standard for diagnosis, insurance documentation, and clinical research. At DiseaseMaps.org, our community of 31 members uses this term to connect with others who share similar experiences, ensuring that patients and doctors remain on the same page regarding care.

Next steps

• Consult a neuromuscular specialist or a neurologist who has experience managing channelopathies.


• Request genetic testing to determine if your Hypokalemic periodic paralysis is Type 1 or Type 2, as this can influence treatment approaches.


• Join the DiseaseMaps.org community to connect with other patients and share experiences regarding symptom management.


• Keep a detailed diary of your episodes, including diet and potential triggers, to share with your healthcare team.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Rare Disease Database (ORPHA:684).


• NIH Genetic and Rare Diseases (GARD) Information Center.


• OMIM (Online Mendelian Inheritance in Man) database entries #170400 and #613345.


• The Periodic Paralysis Association (PPA) clinical resource archives.